Overview

uPAR-PET/MRI in Glioblastoma Multiforme

Status:
Unknown status

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the applicability of urokinase plasminogen activator receptor (uPAR) Positron Emission Tomography (PET) / MRI molecular imaging of glioblastoma.

Phase:

Phase 2

Details

Lead Sponsor:

Rigshospitalet, Denmark